Golden Biotechnology Corporation (TPEX:4132)

Golden Biotechnology Statistics

Total Valuation

TPEX:4132 has a market cap or net worth of TWD 1.85 billion. The enterprise value is 2.00 billion.

Market Cap	1.85B
Enterprise Value	2.00B

Important Dates

The next estimated earnings date is Friday, August 15, 2025.

Earnings Date	Aug 15, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:4132 has 162.23 million shares outstanding. The number of shares has increased by 5.90% in one year.

Current Share Class	162.23M
Shares Outstanding	162.23M
Shares Change (YoY)	+5.90%
Shares Change (QoQ)	+11.79%
Owned by Insiders (%)	13.11%
Owned by Institutions (%)	0.06%
Float	140.95M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	45.20
PB Ratio	6.05
P/TBV Ratio	6.67
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.54
EV / Sales	48.83
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.57

Financial Position

The company has a current ratio of 0.92, with a Debt / Equity ratio of 1.20.

Current Ratio	0.92
Quick Ratio	0.64
Debt / Equity	1.20
Debt / EBITDA	n/a
Debt / FCF	-1.39
Interest Coverage	-42.47

Financial Efficiency

Return on equity (ROE) is -101.91% and return on invested capital (ROIC) is -33.19%.

Return on Equity (ROE)	-101.91%
Return on Assets (ROA)	-31.13%
Return on Invested Capital (ROIC)	-33.19%
Return on Capital Employed (ROCE)	-94.82%
Revenue Per Employee	335,393
Profits Per Employee	-2.96M
Employee Count	122
Asset Turnover	0.06
Inventory Turnover	0.72

Taxes

In the past 12 months, TPEX:4132 has paid 118,000 in taxes.

Income Tax	118,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -47.71% in the last 52 weeks. The beta is 0.85, so TPEX:4132's price volatility has been lower than the market average.

Beta (5Y)	0.85
52-Week Price Change	-47.71%
50-Day Moving Average	12.68
200-Day Moving Average	15.03
Relative Strength Index (RSI)	29.05
Average Volume (20 Days)	386,336

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:4132 had revenue of TWD 40.92 million and -360.70 million in losses. Loss per share was -2.39.

Revenue	40.92M
Gross Profit	-7.01M
Operating Income	-357.70M
Pretax Income	-360.58M
Net Income	-360.70M
EBITDA	-329.94M
EBIT	-357.70M
Loss Per Share	-2.39

Balance Sheet

The company has 218.85 million in cash and 367.36 million in debt, giving a net cash position of -148.51 million or -0.92 per share.

Cash & Cash Equivalents	218.85M
Total Debt	367.36M
Net Cash	-148.51M
Net Cash Per Share	-0.92
Equity (Book Value)	305.76M
Book Value Per Share	1.88
Working Capital	-26.45M

Cash Flow

In the last 12 months, operating cash flow was -263.11 million and capital expenditures -937,000, giving a free cash flow of -264.04 million.

Operating Cash Flow	-263.11M
Capital Expenditures	-937,000
Free Cash Flow	-264.04M
FCF Per Share	-1.63

Margins

Gross Margin	-17.14%
Operating Margin	-874.18%
Pretax Margin	-881.22%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TPEX:4132 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.90%
Shareholder Yield	n/a
Earnings Yield	-19.50%
FCF Yield	-14.28%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:4132 has an Altman Z-Score of 0.98 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.98
Piotroski F-Score	1